Asymmetric reduction of 3-oxo-3-phenylpropionic acid ethyl ester by undifferentiated cells of white turnip in phosphate buffer/organic solvent

2010 ◽  
Vol 28 (2) ◽  
pp. 378-382 ◽  
Author(s):  
Zhimin Ou ◽  
Qingmei Chen ◽  
Gensheng Yang ◽  
Li Xu
2018 ◽  
Vol 921 ◽  
pp. 54-59
Author(s):  
Zhi Hin Ou ◽  
Jia Hui Xu

S-licarbazepine was synthesized by asymmetric reduction of oxcarbazepine in organic solvent/phosphate buffer biphasic system with Bacillus anthracis CGMCC No.12337 as catalyst. Effects of many factors on reduction were studied. Dibutyl phthalate/phosphate buffer was selected as the optimal biphasic system for reduction. The optimum reduction conditions are as follows: volume ratio of dibutyl phthalate and phosphate buffer 1:1, 30 g/L iospropanol as co-substrate, phosphate buffer pH 5, substrate concentration 7.92 mmol/L, cell concentration 30 g/L, 32°C,180 rpm. The conversion and enantiometric excess of S-licarbazepine reached 97.32% and 99.80%. An efficient method for synthesis of S-licarbazepine was provided.


ChemInform ◽  
2010 ◽  
Vol 27 (41) ◽  
pp. no-no
Author(s):  
A. CHADHA ◽  
M. MANOHAR ◽  
T. SOUNDARARAJAN ◽  
T. S. LOKESWARI

2012 ◽  
Vol 560-561 ◽  
pp. 273-278
Author(s):  
Zhi Min Ou ◽  
Ying Kang Nan

An efficient yeast cell biotransformation process was set up for asymmetric synthesis of (R)-(-)-mandelic acid ethyl ester, a key drug intermediate. Saccharomyces cerevisiae 21 was selected as optimum strain for biotransformation. The optimum reduction conditions are as follows: substrate concentration 20 g/L, cell concentration 140 g/L, reaction time 36 h, temperature 30 0C. Conversion and enantiometric excess of (R)-(-)-mandelic acid ethyl ester reached 99.8 % and 100%.


1996 ◽  
Vol 7 (6) ◽  
pp. 1571-1572 ◽  
Author(s):  
A. Chadha ◽  
M. Manohar ◽  
T. Soundararajan ◽  
T.S. Lokeswari

Sign in / Sign up

Export Citation Format

Share Document